Pacific Biosciences (PACB)

$1.78 +0.15 (9.20%)
Market Cap 492.11M
Revenue (ttm) 160.01M
Net Income (ttm) -546.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -341.47%
Debt to Equity Ratio 0.00
Volume 4,674,000
Avg Vol 7,398,634
Day's Range N/A - N/A
Shares Out 301.91M
Stochastic %K 55%
Beta 2.27
Analysts Sell
Price Target $2.50

Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleas...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 521 8000
Address:
1305 O’Brien Drive, Menlo Park, United States
nWhiteface
nWhiteface Feb. 27 at 1:41 AM
$PACB looking to load up. How's the water?
0 · Reply
patten1962
patten1962 Feb. 27 at 1:06 AM
$PACB Why we up today?
0 · Reply
2Haflingers
2Haflingers Feb. 26 at 9:05 PM
$PACB Added this morning at 1.64 turned a red day around..
1 · Reply
Furderber
Furderber Feb. 26 at 8:53 PM
$PACB Good time to buy PACB
0 · Reply
selftaught
selftaught Feb. 26 at 8:37 PM
$PACB Loving it! Next one that is setup very similar to this is $ARTW
0 · Reply
selftaught
selftaught Feb. 26 at 5:41 PM
$PACB coiling.
1 · Reply
Firefly210
Firefly210 Feb. 26 at 4:54 PM
$PACB let’s go already!!!
0 · Reply
x404
x404 Feb. 26 at 4:13 PM
$PACB
0 · Reply
d_risk
d_risk Feb. 25 at 9:08 PM
$PACB - Pacific Biosciences of California Inc - 10K - Updated Risk Factors PACB flags a major new risk from selling off its short-read sequencing assets (while retaining some legacy liabilities), amplifies exposure to aggressive new US/China tariff and export-control regimes, and highlights heightened uncertainty from shifting FDA, NIH funding, biosecurity laws, and data-transfer restrictions. #Biotechnology #AssetDivestiture #USChinaTariffs #RegulatoryUncertainty #BiosecurityRisks 🟢 Added 🟠 Removed https://d-risk.ai/PACB/10-K/2026-02-25
1 · Reply
Furderber
Furderber Feb. 25 at 8:30 PM
$PACB PACB working back to 2. REKR appears to be breaking out.
0 · Reply
Latest News on PACB
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

Feb 24, 2026, 9:05 AM EST - 2 days ago

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 18, 2026, 4:05 PM EST - 8 days ago

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call Transcript

Feb 14, 2026, 7:27 AM EST - 12 days ago

Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call Transcript

PacBio Completes Sale of Short-Read Sequencing Assets

Feb 2, 2026, 9:05 AM EST - 24 days ago

PacBio Completes Sale of Short-Read Sequencing Assets

PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation

Jan 28, 2026, 12:16 PM EST - 4 weeks ago

PacBio: The Consumables Flywheel Is Turning. The Chart Wants Confirmation

PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 27, 2026, 4:05 PM EST - 4 weeks ago

PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:55 PM EST - 6 weeks ago

Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

Jan 12, 2026, 9:15 AM EST - 6 weeks ago

PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

Jan 12, 2026, 9:05 AM EST - 6 weeks ago

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

Jan 8, 2026, 9:05 AM EST - 7 weeks ago

PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 4:05 PM EST - 2 months ago

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 28, 2025, 9:05 AM EST - 3 months ago

PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Pacific Biosciences of California, Inc. (PACB) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 9:41 PM EST - 4 months ago

Pacific Biosciences of California, Inc. (PACB) Q3 2025 Earnings Call Transcript

HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes

Nov 5, 2025, 9:05 AM EST - 4 months ago

HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

Nov 4, 2025, 9:05 AM EST - 4 months ago

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 22, 2025, 4:05 PM EDT - 4 months ago

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

Oct 14, 2025, 6:05 AM EDT - 4 months ago

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project

Oct 13, 2025, 9:05 AM EDT - 4 months ago

PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project

Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity

Oct 8, 2025, 9:05 AM EDT - 5 months ago

Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity

PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs

Oct 7, 2025, 9:05 AM EDT - 5 months ago

PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

Sep 22, 2025, 9:05 AM EDT - 5 months ago

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:45 PM EDT - 6 months ago

Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow

Sep 3, 2025, 9:05 AM EDT - 6 months ago

PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow

Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 8:18 PM EDT - 7 months ago

Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call Transcript

PacBio to Present at Upcoming Investor Conferences

Aug 6, 2025, 9:00 AM EDT - 7 months ago

PacBio to Present at Upcoming Investor Conferences

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Aug 4, 2025, 9:05 AM EDT - 7 months ago

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Jul 29, 2025, 8:52 AM EDT - 7 months ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

DGX

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Jul 24, 2025, 9:05 AM EDT - 7 months ago

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

Jul 23, 2025, 9:05 AM EDT - 7 months ago

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 21, 2025, 4:05 PM EDT - 7 months ago

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Jun 2, 2025, 10:00 AM EDT - 9 months ago

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

May 12, 2025, 10:56 AM EDT - 10 months ago

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:08 PM EDT - 10 months ago

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

PacBio Announces First Quarter 2025 Financial Results

May 8, 2025, 4:15 PM EDT - 10 months ago

PacBio Announces First Quarter 2025 Financial Results

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

May 5, 2025, 9:05 AM EDT - 10 months ago

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

Apr 28, 2025, 9:05 AM EDT - 10 months ago

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

Apr 22, 2025, 9:05 AM EDT - 11 months ago

Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

Apr 9, 2025, 9:05 AM EDT - 11 months ago

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

PacBio Grants Equity Incentive Award to New Employee

Apr 4, 2025, 7:45 PM EDT - 11 months ago

PacBio Grants Equity Incentive Award to New Employee

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Mar 27, 2025, 9:22 AM EDT - 1 year ago

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Jim Gibson to join PacBio as Chief Financial Officer

Mar 27, 2025, 9:05 AM EDT - 1 year ago

Jim Gibson to join PacBio as Chief Financial Officer

Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

Mar 17, 2025, 9:05 AM EDT - 1 year ago

Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock

Feb 25, 2025, 10:26 PM EST - 1 year ago

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

Feb 19, 2025, 4:05 PM EST - 1 year ago

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference

Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 9:09 PM EST - 1 year ago

Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript

Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN TXG

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

Feb 3, 2025, 9:05 AM EST - 1 year ago

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

Jan 30, 2025, 4:05 PM EST - 1 year ago

PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

PacBio Announces Appointment of Chris Smith to Board of Directors

Jan 30, 2025, 9:05 AM EST - 1 year ago

PacBio Announces Appointment of Chris Smith to Board of Directors

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

Jan 29, 2025, 9:05 AM EST - 1 year ago

PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics

nWhiteface
nWhiteface Feb. 27 at 1:41 AM
$PACB looking to load up. How's the water?
0 · Reply
patten1962
patten1962 Feb. 27 at 1:06 AM
$PACB Why we up today?
0 · Reply
2Haflingers
2Haflingers Feb. 26 at 9:05 PM
$PACB Added this morning at 1.64 turned a red day around..
1 · Reply
Furderber
Furderber Feb. 26 at 8:53 PM
$PACB Good time to buy PACB
0 · Reply
selftaught
selftaught Feb. 26 at 8:37 PM
$PACB Loving it! Next one that is setup very similar to this is $ARTW
0 · Reply
selftaught
selftaught Feb. 26 at 5:41 PM
$PACB coiling.
1 · Reply
Firefly210
Firefly210 Feb. 26 at 4:54 PM
$PACB let’s go already!!!
0 · Reply
x404
x404 Feb. 26 at 4:13 PM
$PACB
0 · Reply
d_risk
d_risk Feb. 25 at 9:08 PM
$PACB - Pacific Biosciences of California Inc - 10K - Updated Risk Factors PACB flags a major new risk from selling off its short-read sequencing assets (while retaining some legacy liabilities), amplifies exposure to aggressive new US/China tariff and export-control regimes, and highlights heightened uncertainty from shifting FDA, NIH funding, biosecurity laws, and data-transfer restrictions. #Biotechnology #AssetDivestiture #USChinaTariffs #RegulatoryUncertainty #BiosecurityRisks 🟢 Added 🟠 Removed https://d-risk.ai/PACB/10-K/2026-02-25
1 · Reply
Furderber
Furderber Feb. 25 at 8:30 PM
$PACB PACB working back to 2. REKR appears to be breaking out.
0 · Reply
patten1962
patten1962 Feb. 25 at 12:09 PM
$PACB ●Last 3 earnings, BEAT!!!!! ●Keep seeing news of new partnerships! ●So far Cathie and Softbank still holding shares! Gotta think this will run soon!
1 · Reply
selftaught
selftaught Feb. 24 at 5:28 PM
$PACB looks like we are going to get a retest of the 200dma instead
0 · Reply
selftaught
selftaught Feb. 24 at 5:17 PM
$PACB really want to see this get over 1.68
0 · Reply
TheTradeXchange
TheTradeXchange Feb. 24 at 2:05 PM
$PACB - PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease ResearchCollaboration powers secure international data sharing through the HiFi Solves Global Consortium
0 · Reply
Pidxr
Pidxr Feb. 24 at 12:28 PM
In no particular order $PACB $DVLT $IBRX $EZRA $THR
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 10:11 PM
$PACB Current Stock Price: $1.58 Contracts to trade: $1.5 PACB Mar 20 2026 Call Entry: $0.15 Exit: $0.20 ROI: 32% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
selftaught
selftaught Feb. 23 at 8:00 PM
$LXRX $ARTW $BWEN $OCGN $PACB all holding up well considering the current market. Obviously some better than others. But I was expecting worse.
1 · Reply
x404
x404 Feb. 23 at 3:53 PM
$PACB n.v.m i think we may even see 1.40.🙏
0 · Reply
x404
x404 Feb. 23 at 3:31 PM
$PACB you guys think we may see 1.50? I want to buy more but still observing 😬
1 · Reply
SPY700baby
SPY700baby Feb. 22 at 1:30 AM
$PACB about to fly
0 · Reply
Tennis2012
Tennis2012 Feb. 21 at 4:29 PM
$PACB nice new infos at zack!! Buy rate 1...
1 · Reply
Vladxccc
Vladxccc Feb. 21 at 3:56 PM
$PACB I bought 2k shares at $1.60 yesterday
0 · Reply